baber/WOPTO huggingface dataset:
Patent CA-2550149-A1 (CA)
Title: Tailgate assemblies
Inventor: LIBBY RODNEY EUGENE
IPC: B62D33/03
Filed: 2004-12-02
Abstract: Tailgate assemblies that are easier to use than tailgate assemblies of the prior art are provided. The tailgate assemblies comprise one or more torsion springs having a first leg attached to a tailgate support and a second leg attached to the tailgate. The legs of the torsion spring can be removably attached for easier replacement. The torsion springs are actuated in a winding direction as the tailgate is opened, making the tailgate easier to open and close.
Patent CA-2552370-A1 (CA)
Title: Method to manufacture metallized paper with curtain coating
Inventor: ORTEGA MAHAVE LUIS AMANDO
IPC: B05D5/06
Filed: 2003-12-30
Abstract: The invention relates to a method of producing metallised paper by means of curtain coating. The inventive method comprises the following steps consisti ng in: applying a first aqueous film-forming composition to a substrate by mean s of curtain coating, metallising the coated substrate, and applying a second aqueous film-forming composition to said metallised substrate by means of curtain coating. The invention is characterised in that the first and/or second aqueous film-forming composition comprises a first polymer in emulsio n and/or a second polymer in colloidal dispersion.
Patent CA-2554073-A1 (CA)
Inventor: GLENNON JEFFREY C
IPC: A61P25/16
Filed: 2005-03-23
Abstract: The invention relates to a novel use of known 1-[2H-1-benzopyran-2-one-8-yl]~piperazine derivatives, broad spectrum 5-HT receptor binding compounds, having amongst other functional serotonin receptor activities, potent 5-HT1A  receptor agonistic activity, 5-HT1D receptor antagonistic activity and 5-HT7 receptor agonistic activity. The compounds of the invention are useful for the preparation of medicaments for treating, ameliorating or preventing movement disorders. The invention relates to compounds of the general formula (1) (1) wherein the symbols have the meanings as given in the description.
Patent CA-2554302-A1 (CA)
Title: Perylene n-type semiconductors and related devices
Inventor: MARKS TOBIN J
IPC: C07D221/14
Filed: 2005-01-26
Abstract: Mono- and diimide perylene and naphthalene compounds, N- and core substituted with electron-withdrawing groups, for use in the fabrication of various device structures.
Patent CA-2555809-A1 (CA)
Inventor: DOELING FABIAN
IPC: D21G1/02
Filed: 2005-01-21
Abstract: Disclosed is a method for heating a roller that is used for producing and/or refining a web of material, particularly a paper web or cardboard web.  According to said method, the heat required for heating the roller is generated at least in part within the roller by burning a combustible material at least in some areas of the roller with the aid of air or oxygen. Also disclosed is a corresponding heatable roller.
Patent CA-2556710-A1 (CA)
Title: Calibration of downlink and uplink channel responses in a wireless mimo communication system
Inventor: WALTON JAY RODNEY
IPC: H04B17/00
Filed: 2005-02-18
Abstract: The downlink and uplink are calibrated to account for differences in the responses of transmit and receive chains at an access point and a user terminal. For initial calibration, the access point and user terminal transmit MIMO pilots on the downlink and uplink, which are used to derive channel estimates including the responses of the applicable transmit/receive chains.  Correction matrices (a) and (b) are derived based on these channel estimates and thereafter used by the access point and user terminal, respectively. For follow-on calibration, one entity transmits a MIMO pilot and a steered reference. The other entity derives a first transmit matrix based on the steered reference and a second transmit matrix based on the MIMO pilot and calibration error matrices (c) and (d), which contain estimates of the errors in (a) and (b), respectively. (c) and (d) may be iteratively adjusted based on an adaptive procedure to minimize the errors between the two transmit matrices.
Patent CA-2558905-A1 (CA)
Title: Refractory articles for guiding or conveying a solidified material and process for the manufacture thereof
Inventor: DEREMETZ JACKY
IPC: C03C14/00
Filed: 2005-04-01
Abstract: The present invention relates to refractory articles for guiding or conveying a solidified material comprising a vitreous silica basis, in particular rollers or guiding elements and to a process for the manufacture of said articles which do not show the pickup problems normally observed with the articles of the art. The refractory articles of the invention comprise a vitreous bases and, homogeneously distributed therein, a carbonaceous material.
Patent CA-2559959-A1 (CA)
Title: Methods for the preparation of (3r,3as,6ar) hexahydro-furo[2,3-b]furan-3-ol
Inventor: LOMMEN FRANCISCUS ALPHONS MARI
IPC: C07D493/04
Filed: 2005-03-31
Abstract: The present invention relates to methods for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol (6) as well as a novel intermediate, (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one (4) for use in said methods. More in particular the invention relates to a stereoselective method for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol, as well as methods for the crystallization of (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan- 2-one and for the epimerization of (3aR,4R,6aS) 4-methoxy-tetrahydro-furo[3,4-b]-furan-2-one to (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one.
Patent CA-2560447-A1 (CA)
Inventor: ROYER ANTHONY SCOTT
IPC: F16B1/00
Filed: 2006-09-21
Abstract: A lock for an implement turnbuckle includes an apertured plate attached directly to the turnbuckle. The plate receives the pin or linkage connecting structure that attaches to the threaded eyebolt of the turnbuckle. The mounting end of the plate opposite the slot is secured against a flat on the internally threaded member of the turnbuckle by a U-bolt. The plate prevents relative rotation between the eyebolt and an internally threaded member receiving the eyebolt to thereby maintain the desired turnbuckle length adjustment.
Patent CA-2561300-A1 (CA)
Inventor: SUZUKI TAKAYUKI
IPC: B60C11/13
Filed: 2005-12-26
Abstract: A pneumatic tire having grooves formed in its tread section and having blocks partitioned by the grooves. A pair of blocks adjacent to each other across a groove is chosen, two perpendiculars are individually drawn from two vertexes, located on the groove side, of the vertexes of either of the blocks to the other block, and the feet of the perpendiculars are connected with a line segment along the outer periphery of the block. The lengths of the line segments are compared between the blocks, and a shorter line segment is defined as a facing length c. The ratio c/b, or the ratio between the facing length c and the width b of a groove, is within the range of 0.50 <= c/b <=  1.30.
Patent CA-2563419-A1 (CA)
Title: Methods and systems for sorting unaddressed items
Inventor: WONG WILSON
IPC: B07C5/00
Filed: 2004-09-30
Abstract: Systems and methods for sorting a plurality of unaddressed items may comprise receiving delivery point address data. Furthermore, systems and methods for sorting a plurality of unaddressed items may comprise sorting the plurality of unaddressed items based on the delivery point address data. The plurality of unaddressed items may be sorted in an order in which they are to be delivered within a delivery zone specified by the delivery point address data.
Patent CA-2563449-A1 (CA)
Title: Rotary locking mechanism for outside vehicle door handle
Inventor: JANKOWSKI KRYSTOF P
IPC: E05B65/20
Filed: 2005-05-02
Abstract: A locking device is provided for preventing a motor vehicle door from opening when a handle portion of a handle assembly moves with acceleration above a predetermined threshold relative to a base thereof. The locking device includes a lock cup fixedly secured to the base and having a plurality of teeth. The locking device also includes a spool rotatably coupled to the lock cup and operably connected to the handle portion. The spool includes a pawl rotatably mounted thereto. The locking device further includes an inertia element disposed between the lock cup and the spool. The inertia element is coupled to the pawl such that upon the acceleration above the predetermined threshold the inertia element lags rotation of the spool and forces the pawl into engagement with one of the plurality of teeth to stop movement of the handle portion relative to the base and prevent the door from opening.
Patent CA-2565336-A1 (CA)
Inventor: BURNOUF THIERRY
IPC: A61L2/00
Filed: 2006-02-01
Abstract: The invention relates to a set system of disposable bags comprising at least one viral inactivation bag (1), comprising an inner compartment (4) , an inlet facility (5) and an outlet facility (6) , which are both connected to the inner compartment (4), the bag (1) being characterised in that the inner compartment (4) has an ovoid longitudinal section, and at least one funnel bag (9), and/or a column chromatography bag (15), the different bags being connectable with each other, and to the use of said set system of disposable bags for the viral inactivation of biological fluids with excellent protein recovery.
Patent CA-2567894-A1 (CA)
Title: Method of dispersing hydrocarbon foulants in hydrocarbon processing fluids
Inventor: HOWDESHELL MICHAEL JAMES
IPC: C10G9/16
Filed: 2005-04-27
Abstract: A method of dispersing, dissolving, or reducing the viscosity of hydrocarbon foulants including heavy oil, tars, asphaltenes, polynuclear aromatic hydrocarbons, coke, polymers, light oil, oxidized hydrocarbon and thermal decomposition products, and the like in fluids in contact with hydrocarbon processing equipment comprising contacting the foulant with an effective amount of a halogen-free organic solvent having a density greater than water at the processing temperature.
Patent CA-2570668-A1 (CA)
Inventor: MOEN RICHARD A
IPC: B60K11/08
Filed: 2006-12-05
Abstract: A grille arrangement for an enclosure of a drive unit of a self-propelled agricultural applicator is provided. The grille arrangement includes a screen, and a frame mounted by the screen. The frame includes a first strut connected by at least one movable latch assembly to the enclosure, and a second strut having a first linear portion aligned at an obtuse angle relative to a second linear portion in top plan view. The screen is attached at the first linear portion. With the frame and screen aligned at the obtuse angle relative to a vertical plane perpendicular to a forward direction of travel, the second linear portion slides into a notch at a vertical support strut fixed at the enclosure. Upon sliding the second linear portion in the notch, rotation of the frame rotates the second linear portion to a lock position securing the frame and screen at the enclosure.
Patent CA-2572939-A1 (CA)
Title: Mini pad for reducing inflammation of the vulva and method of making the same
Inventor: RENZIN STEPHEN M
IPC: A61L15/46
Filed: 2005-07-20
Abstract: A mini pad is provided with a chilled skim milk additive which is useful for reducing vulvar inflammation and lowering the acidity of a female's vulva which result from vaginal secretions which leak onto the tissue of the vulva.The mini pad canbe provided with a self-contained component which can be frozen or, when compressed and ruptured, will lower the temperature of the mini pad to provide the soothing cold. The skim milk can be incorporated into the mini pad in several different ways. The mini pad is useful for soothing and healing vulvar irritation, and it is mobileand can be easily used during normal daily activities without any problems whatsoever.
Patent CA-2576884-A1 (CA)
Inventor: SRA JASBIR S
IPC: A61B5/04
Filed: 2005-08-12
Abstract: A catheter apparatus is provided for use in the treatment of heart arrhythmia having a catheter shaft, a mapping and ablation catheter disposed within the shaft, and a control mechanism coupled to both the shaft and catheter. The catheter shaft includes a main body and a coaxial tip section joined to the main body. The tip section can be rotated about a central axis and curved away from the central axis in a controlled manner. The mapping and ablation catheter can be extended outward from the catheter shaft where it is able to take the form of a pre-stressed curve. The control mechanism controls axial rotation of the tip section, the degree of deflection of the tip section and longitudinal movement of the mapping and ablation catheter with respect to the catheter shaft. Preferably, the mapping and ablation catheter forms a pre-stressed loop when it is fully extended from the catheter shaft. In another aspect of this invention, it provides a method for treatment of a heart arrhythmia having the steps of (1) obtaining cardiac image data from a medical imaging system, (2) creating a 3D model from this cardiac image data, (3) registering the 3D model to an interventional system, (4) positioning the catheter apparatus within a chamber of the heart, (5) displaying the catheter apparatus over the registered 3D model on the interventional system, (6) navigating the catheter apparatus within the heart guided by the registered 3D  model, and (7) having the catheter apparatus ablate heart tissue at select locations.
Patent CA-2581862-A1 (CA)
Title: Process for producing lithium transition metal oxides
Inventor: HOSSAIN MOHAMMAD JAHANGIR
IPC: C01G45/04
Filed: 2005-06-06
Abstract: A direct low temperature process for lithiating hydroxides and forming lithiated transition metal oxides of suitable crystallinity. Elemental transition metal powders are combined with an aqueous solution of lithium hydroxide. The aqueous slurry solution is subject to oxidation. The resultant lithium transition metal oxide is crystallized in-situ and subsequently removed from the reactor.
Patent CA-2583646-A1 (CA)
Title: Isomeric mixtures of dinitro-octylphenyl esters and synergistic fungicidal mixtures therefrom
Inventor: DISTLER BERNHARD
IPC: A01N37/06
Filed: 2005-10-14
Abstract: The present invention relates to an isomeric composition comprising isomers of dinitro-octylphenyl esters, wherein the 2,6-dinitro-4-(1-propylpentyl)phenyl ester isomer is present in an amount of less than 0.1 weight percent, based on the total weight of the isomeric composition and to synergistic fungicidal mixtures therefrom.
Patent CA-2583703-A1 (CA)
Inventor: KROEGER BURKHARD
IPC: C12Q1/68
Filed: 2000-06-23
Abstract: Isolated nucleic acid molecules, designated MCT nucleic acid molecules, which encode novel MCT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MCT nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MCT proteins, mutated MCT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C.  glutamicum based on genetic engineering of MCT genes in this organism.
Patent CA-2585235-A1 (CA)
Inventor: DAMUDE HOWARD G
IPC: A23L27/00
Filed: 2005-11-03
Abstract: An engineered strain of the oleaginous yeast Yarrowia lipolytica capable of producing greater than 5.6% docosahexaenoic acid acid (DHA, an .omega.-3 polyunsaturated fatty acid) in the total oil fraction is described. This strain comprises various chimeric genes expressing heterologous desaturases, elongases and acyltransferases and optionally comprises various native desaturase and acyltransferase knockouts to enable synthesis and high accumulation of DHA. Production host cells are claimed, as are methods for producing DHA within said host cells.
Patent CA-2588399-A1 (CA)
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2005-11-18
Abstract: This invention discloses 2.alpha.-methyl-19-nor-(20S)-vitamin D analogs, and specifically 2.alpha.-methyl-l9-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
Patent CA-2593113-A1 (CA)
Inventor: MILLER MICHAEL E
IPC: A61B10/00
Filed: 2006-02-10
Abstract: A tissue removal apparatus having a cutting element mounted to a handpiece.  The cutting element includes an outer cannula defining a tissue-receiving opening and an inner cannula concentrically disposed within the outer cannula.  The outer cannula has a trocar tip at its distal end and a cutting board snugly disposed within the outer cannula. The inner cannula defines an inner lumen that extends the length of the inner cannula, and which provides an avenue for aspiration. The inner cannula terminates in an inwardly beveled, razor-sharp cutting edge and is driven by a single motor that causes both rotary and reciprocating movement of the inner cannula.
Patent CA-2593800-A1 (CA)
Title: Improved venting system for minimizing condensation in a lighting assembly
Inventor: DE WITT KERRY L
IPC: B01D53/26
Filed: 2006-01-09
Abstract: In one aspect, the invention is a lighting assembly comprising a housing (20) defining an internal space within the housing, and an ambient space surrounding the housing, a light source within the internal space; a high capacity desiccant (22) being nonregenerating at temperatures of up to about 50 degrees Celsius and about 11.0% relative humidity; and a diffusion tube (12) having a first opening proximate to the internal space and a second opening proximate to the ambient space, the diffusion tube providing gaseous communication between the internal space and the ambient space.
Patent CA-2594569-A1 (CA)
Title: Synthesis of sodium narcistatin and related compounds
Inventor: MELODY NOELEEN
IPC: A61K31/443
Filed: 2006-01-17
Abstract: The present invention involves use of the compounds narciclasine (2a) and 7-deoxy-narciclasine (2c), which are obtained via isolation from the medicinal plant species Narcissus (Amaryllidaceae), as precursors in a novel synthesis method in which each of these compounds are selectively hydrogenated to produce trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c). Also described herein is a novel synthesis method for producing sodium narcistatin (11) from narciclasine (2a). Further described herein are certain novel 3,4-cyclic phosphate prodrugs, including sodium-7-deoxynarcistatin (8), sodium-7-deoxy-transdihydronarcistatin (9), and sodium transdihydronarcistatin (10).
Patent CA-2594861-A1 (CA)
Title: Processing apparatus and methods
Inventor: ANDRE AXEL GUENTHER
IPC: B01F27/94
Filed: 2005-01-14
Abstract: The invention relates to processing apparatus and methods and in particular, but not exclusively, to an apparatus that may be used to process a wide variety of feed materials by one or more of milling or grinding, mixing, blending, separation, drying and sterilisation. In a preferred embodiment there is provided a feed material processing apparatus (1) comprising: a chamber (2); at least one inlet (4) in flow communication to an upper region of the chamber (2); a rotor (3) located within the chamber (2) that is rotatable about a substantially vertical axis by a rotation drive (11), wherein the rotor (3) promotes a circulatory flow of feed material and/or gas within the chamber (2); at least one outlet (5) in flow communication from a lower region of the chamber (2). Preferably the apparatus (1) comprises at least one feature located laterally on the rotor (3) to promote the circulatory flow.
Patent CA-2595037-A1 (CA)
Title: Modified tie-2 receptor ligands
Inventor: YANCOPOULOS GEORGE D
IPC: C12N9/12
Filed: 1997-08-01
Abstract: The present invention provides for a modified TIE-2 ligand which has been altered by addition, deletion or substitution of one or more amino acids, or by way of tagging, with for example, the Fc portion of human IgG-1, but which retains its ability ,to bind the TIE-2 receptor. The invention further provides for a modified TIE-2 ligand which is a chimeric TIE-2 ligand comprising at least a portion of a first TIE-2 ligand and a portion of a second TIE-2 ligand which is different from the first. In a specific embodiment, the invention further provides for a chimeric TIE ligand comprising at least a portion of TIE-2 ligand-1 and a portion of TIE-2 ligand-2. In addition the present invention provides for isolated nucleic acid molecule encoding the modified TIE-2 ligands described. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE receptor, a method of blocking the growth or differentiation of a cell expressing the TIE receptor and a method of attenuating or preventing tumor growth in a human
Patent CA-2599848-A1 (CA)
Inventor: DUPONT-PASSELAIGUE ELISABETH
IPC: A61P3/06
Filed: 2006-03-02
Abstract: L'invention concerne des dérivés de la 3,5-dioxo-(2H,4H)-1 ,2,4-triazine de formule générale (I) dans laquelle - R1 et R2 peuvent être identiques ou différents et représentent un radical alkyle ou alkènyle linéaire ou branché  en C1-C7, un radical alkyle en C1-C6 substitué par des groupements tels que, trifluorométhyle, cycloalkyle en C5-C6, nitrile, alkoxycarbonylvinyle en C1-C4, hydroxycarbonylvinyle, alkoxycarbonyle en C1-C4, carboxylate, benzyloxy ou phényle (pour lesquels le noyau phényle est éventuellement substitué par un ou plusieurs groupements tels que alcoyle en C1-C4, alkoxy en C1-C4, nitro, halogène, trifluorométhyle). - YR3 représente l'oxygène ou NR3 pour lequel R3 représente l'hydrogène, un radical alcoyle ou alkènyle linéaire ou branché en C1-C7, un radical alkyle en C1-C6 substitué par des groupements tels que, trifluorométhyle ou phényle (pour lesquels le noyau phényle est éventuellement substitué par un ou plusieurs groupements tels que alcoyle en C1-C4, alkoxy en C1-C4, nitro, halogène, trifluorométhyle) - Z représente un atome d'oxygène ou un atome de carbone pouvant être lié aux positions ortho, meta ou para du groupement phényle de la formule I - n peut-être égal à 0 à 5 lorsque Z=C ou 2 à 4 lorsque Z=O, - X représente l'oxygène ou le soufre - R4, R5, R6, R7 et R8 représentent l'hydrogène ou le fluor, - R9, R10 et R11 représentent l'hydrogène ou un groupement alkyle en C1-C5 linéaire ou branché ainsi que les sels d'addition avec les bases pharmaceutiquement acceptables, et les différents énantiomères des composés possédant des carbones asymétriques, ainsi que leurs mélanges en toutes proportions incluant notamment les mélanges racémiques.